Nasdaq GlobeNewswire

WaferGen Bio-systems Announces ICELL8™ Single-Cell System Placements at the European Molecular Biology Laboratory and Karolinska Institutet

Del

FREMONT, Calif. and LUXEMBOURG, 2016-05-03 23:29 CEST (GLOBE NEWSWIRE) --

WaferGen Bio-systems (NASDAQ:WGBS) announced today that the European Molecular Biology Laboratory (EMBL), an intergovernmental organization specializing in basic research in the life sciences, and Karolinska Institutet, Sweden’s single largest center of medical academic research, have selected the ICELL8™ Single-Cell System for use in their institutions. The system will be used for driving innovative single-cell research in the areas of stem cell and neuroscience research.

“The ability to assess thousands of single cells and select cells of interest with high confidence will provide us with greater understanding of stem cell development and differentiation,” said Dr. Christophe Lancrin, Group Leader at EMBL-Monterotondo.

“We have successfully evaluated the system’s performance to ensure it meets our stringent demands,” said Sten Linnarsson, Professor at Karolinska Institutet. “The system will enable us to accelerate our efforts in identifying and understanding the multiple cell types of the nervous system.”

“The ICELL8 Single-Cell System placements at these leading European research centers are indicative of the growing demand we are seeing for this technology throughout the U.S. and Europe from leading researchers in the field,” said Rollie Carlson, President and CEO WaferGen Biosystems. “These placements represent our initial commercial foray into Europe with the ICELL8 and enhance our position in this large target market.”

The ICELL8 Single-Cell System is a revolutionary platform with the ability to isolate thousands of single cells and process specific cells of interest for downstream analysis using Next Generation Sequencing. The system includes an imaging station and CellSelect™ software for imaging and automatic selection of single cells for downstream processing. The system’s advanced single cell identification and selection provides greater confidence in single-cell analysis results.

About WaferGen
WaferGen Bio-systems, Inc. is a biotechnology company that offers innovative genomic technology solutions for single-cell analysis and clinical research.  The ICELL8™ Single-Cell System is a cutting edge platform which can isolate thousands of single cells and processes specific cells for analysis, including Next Generation Sequencing ("NGS"). The system has demonstrated unbiased isolation of up to 1,800 single cells ranging from 5-100 µm in size on a single chip, including single cells from solid tumors, brain cells, pulmonary airway cells, and multiple cell lines.  The SmartChip™ platform can be used for profiling and validating molecular biomarkers, and can perform massively parallel singleplex PCR for one-step target enrichment and library preparation for clinical NGS.  The Apollo 324™ system can be used to process DNA and RNA from clinical samples to NGS-ready libraries.  These technologies offer a powerful set of tools for biological analysis at the molecular and single cell level in the life sciences, pharmaceutical, and clinical laboratory industries.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that are intended to be covered by the “safe harbor” created by those sections.  Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,” “could,” “seek,” “intend,” “plan,” “estimate,” “anticipate” or other comparable terms.  Forward-looking statements in this press release may address the following subjects among others: statements regarding the sufficiency of our capital resources, expected operating losses, expected revenues, expected expenses, expected cash usage, our expectations regarding our development of future products including single cell analysis technologies and our expectations concerning our competitive position and business strategy.  Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q.  We urge you to consider those risks and uncertainties in evaluating our forward-looking statements.  We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made.  Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

         INVESTOR CONTACTS:
         LifeSci Advisors, LLC
         Brian Ritchie
         BRitchie@LifeSciAdvisors.com
         
         WaferGen Bio-systems, Inc.
         Rollie Carlson
         Rollie.Carlson@wafergen.com

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Dog Meat Free Indonesia : Sickening animal cruelty at Indonesia's "extreme" markets where dogs and cats are bludgeoned, blowtorched alive24.1.2018 09:30Pressemelding

Government urged to take immediate action to protect animals and public health LONDON, Jan. 24, 2018 (GLOBE NEWSWIRE) -- The Indonesian government is being urged to shut down the country's cruel live animal markets, where thousands of dogs and cats a week are bludgeoned in public, blowtorched whilst still alive, and butchered for eating. Campaigners from the Dog Meat-Free Indonesia coalition filmed at two of the most notorious of Indonesia's 200 live animal markets in North Sulawesi, "Tomohon Extreme Market" and Langowan Market, to expose the horrifying suffering routinely endured by animals. Live dogs and cats are seen trembling in cages as one by one they are beaten over the head, howling in pain. Lola Webber, Dog Meat-Free Indonesia campaign coordinator, said: " It was like walking through hell. The dogs huddled together in cages , trembling with fear as they watched others being killed around them , waiting their turn. The sight of absolute terror in their eyes, the thumping of the

Promethean Expands Educational Display Portfolio to Create Immersive Classroom Experiences24.1.2018 09:18Pressemelding

Seattle, Wash., Jan. 24, 2018 (GLOBE NEWSWIRE) -- Promethean TM, a global education technology company, announced expansions to its interactive flat panel portfolio which includes the market-leading ActivPanel and ActivPanel i-Series. The ActivPanel continues to offer the industry's most natural writing experience using InGlassTM technology, enabling both teachers and students to collaborate in front of the class with ease. The ActivPanel i-Series is an essential interactive flat panel for customers looking to replace their projector-based systems with a long-term, reliable solution. "Educators want technology that works as they do - flexible and able to adapt to their teaching styles in any classroom setting," said Ravi Angadi, Chief Products and Strategy Officer, Promethean. "At Promethean, we strive to create a dynamic ecosystem to enhance teacher productivity, providing educators with the latest innovative education technologies that are intuitive and immersive. With access to an e

Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer23.1.2018 21:11Pressemelding

DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of cancer death worldwide. To ensure that clinicians stay apace and provide optimal patient care, three leading medical societies-the College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP)-have updated their 2013 evidence-based guideline. Published today in early online release, the "Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors," continues to set standards for the molecular analysis of lung cancers for test results that effectively guide targeted therapy and treatment. Targeted cancer therapies are drugs or other treatments that block the spread of cancer by interfering with specific molec

CashBet Seeks $40 Million for World's Only Complete Crypto-Ready Mobile iGaming Platform23.1.2018 16:31Pressemelding

Gaming and cryptocurrency industry leaders develop blockchain-based iGaming platform improving trust, speed, access, costs, and content availability OAKLAND, Calif., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Leading mobile-first iGaming platform provider CashBet (https://coin.cashbet.com/) today announced it seeks to raise $40 million through an Initial Coin Offering (ICO) to develop the world's first complete crypto-ready mobile iGaming platform. Interactive gaming, which includes real money, social, skill-based, esports and sports betting, hit $91 billion in 2016, led by mobile gaming. Despite strong growth, current iGaming operations continue to face three major issues: trust, speed, and cost. CashBet is the first and only vertically integrated iGaming solution to leverage blockchain technology for transparent operations, increased speed, and lower transaction fees. The CashBet Coin will be available in pre-sale starting January 24, 2018 at 5:00 p.m. GMT, with a 20 percent discount offered.

BrandSafway Announces Acquisition of Venko Groep BV23.1.2018 16:30Pressemelding

Combined customers to benefit from broader range of services and greater depth of expertise KENNESAW, GA, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Brand Industrial Services, known as BrandSafway, has acquired Venko Groep BV, a portfolio company of Mentha Capital, effective January 1, 2018. Moving forward, the company will operate as Venko, A BrandSafway Company and become a part of Brand Energy & Infrastructure Services (Brand) in Europe. "We're excited to announce the closing of the acquisition of Venko," said Dave Witsken, President of Energy and Industrial for BrandSafway. "Venko is a leading offshore coatings maintenance provider for platforms in Europe. By leveraging the highly specialized knowledge and capabilities of Venko, we will be able to provide expanded coatings services to Brand's European customers. At the same time, with our support, Venko will now be able to offer their customers a broader inventory of access equipment and additional industrial services, such as insulation an

Mitratech's TeamConnect Rated Most Widely Used Matter Management System in HBR Consulting's Annual Law Department Survey23.1.2018 15:00Pressemelding

HBR's Annual Survey further validates TeamConnect's market leadership AUSTIN, Texas, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Mitratech, the leading provider of legal, compliance, and risk management software solutions announced that TeamConnect, the market-leading ELM (enterprise legal management) platform, was rated the most widely used matter management system and the second most widely used e-Billing system in the 2017 HBR Consulting (HBR) Law Department Survey. HBR's Law Department Survey released this month rated Mitratech's TeamConnect as the most widely used system for matter management out of the 13 systems included in the survey. All told, Mitratech's ELM solutions accounted for more than a third of the matter management user base. TeamConnect also was rated for the third year in a row as the second most widely used e-Billing system, continuing a years-long trend of customers shifting to Mitratech's integrated ELM platform from other point solutions. Customer satisfaction continues

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom